Special to The Sun
Dr. Priyabrata Mukherjee, a researcher whose work focuses on nanotechnology applications in cancer drug development, has joined the Peggy and Charles Stephenson Cancer Center.
Mukherjee brings with him more than $3 million in National Cancer Institute research funding. He will collaborate with biomedical researchers at the University of Oklahoma Health Sciences Center and nanotechnology investigators at OU Norman to develop nano-based applications for cancer drug development and delivery.
Mukherjee will be appointed an Oklahoma TSET Cancer Research Scholar in recognition of the Oklahoma Tobacco Settlement Endowment Trust’s efforts to reduce the burden of cancer in the state by supporting innovative research. He will also hold the Peggy and Charles Stephenson Chair in Cancer Laboratory Research, one of four endowed chairs funded by the Stephenson’s gift to support the recruitment of outstanding cancer researchers to Oklahoma.